V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330004623 | 330002231 | 1.76 | 78 | Palliative (P) | 2015-02-22 | 2015-02-22 | CARBOPLATIN + CETUXIMAB + FU | N | N | 330019340 | AZACITIDINE |
| 330004624 | 330002231 | 1.76 | 79.15 | Palliative (P) | 2017-04-10 | 2017-04-18 | Paclitaxel 7 day | N | N | 330019340 | OCTREOTIDE |
| 330004625 | 330002231 | 1.53 | null | Curative (C) | 2013-10-04 | 2014-07-27 | Cisplatin + Docetaxel | N | N | 330019340 | METHOTREXATE |
| 330004626 | 330002232 | 1.6 | 63.2 | Palliative (P) | 2017-06-11 | 2017-06-13 | AML Int Guide ADE 10+3+5 (1) | 2 | N | 330019373 | DOCETAXEL + GEMCITABINE |
| 330004627 | 330007236 | 1.82 | null | Palliative (P) | 2013-11-23 | 2014-01-10 | AML Int Guide ADE 10+3+5 (1) | N | N | 330019378 | CISPLATIN + DOCETAXEL |
| 330004628 | 330002233 | 1.56 | 0 | Curative (C) | 2013-06-20 | 2013-06-23 | VIDE | N | N | 330019390 | ETOPOSIDE |
| 330004629 | 330007237 | 1.68 | 53.3 | Palliative (P) | 2016-07-22 | 2016-08-02 | FLUOROURACIL + MITOMYCIN | N | N | 330019393 | CARBOPLATIN + DOXORUBICIN |
| 330004633 | 330002236 | 1.86 | 91.9 | null | 2015-09-05 | 2015-09-05 | Cisplatin + Docetaxel | 02 | N | 330019445 | CARBOPLATIN + RT |
| 330004634 | 330002237 | 1.14 | 41.6 | null | 2017-06-21 | 2017-06-21 | Carboplatin + Pemetrexed | N | N | 330019447 | CARBOPLATIN + VINORELBINE |
| 330004635 | 330002238 | 1.56 | 65 | Palliative (P) | 2012-12-04 | 2014-05-21 | AML17 TRIAL | N | N | 330019454 | CAPECITABINE + RT |
| 330004636 | 330007239 | 1.65 | 89.8 | Curative (C) | null | 2014-05-10 | Paclitaxel 80mg/m2 day 1 8 15 | 1 | N | 330019455 | CISPLATIN + PEMETREXED |
| 330004637 | 330007239 | 1.65 | 102.5 | Curative (C) | 2017-04-10 | 2017-04-11 | Hydroxycarbamide | null | null | 330019455 | OXALIPLATIN + MDG |
| 330004638 | 330007239 | 1.72 | 92.6 | Curative (C) | 2017-12-21 | 2017-12-22 | VDC | 02 | N | 330019455 | FCR |
| 330004639 | 330002239 | 1.53 | 55.8 | Disease modification (D) | null | 2015-07-10 | FEC 100 | N | N | 330019465 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 330004640 | 330002240 | 1.72 | 74.4 | Curative (C) | 2017-02-28 | 2017-03-08 | VAC | 02 | N | 330019466 | CAV |
| 330004641 | 330002241 | 0 | null | Palliative (P) | null | 2015-12-24 | Azacitidine | null | null | 330019481 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 330004643 | 330002243 | null | null | null | null | 2016-07-13 | CYCLO + RITUXIMAB + VINCRISTINE | null | null | 330019485 | CISPLATIN + VINORELBINE |
| 330004644 | 330002244 | 1.67 | 45.6 | Curative (C) | 2016-12-19 | 2016-12-19 | CARBOPLATIN + RT | N | N | 330019489 | CAPECITABINE + CISPLATIN |
| 330004645 | 330002245 | 1.8 | 75.7 | Adjuvant (A) | 2013-01-14 | 2013-01-17 | Imatinib 400mg | 2 | N | 330019494 | DOXORUBICIN + IFOSFAMIDE |
| 330004646 | 330002246 | null | 25.5 | null | 2013-04-13 | 2013-04-14 | GDP | 02 | N | 330019497 | CARBOPLATIN + RT |
| 330004647 | 330002247 | 0 | 95.1 | Palliative (P) | 2016-06-10 | 2016-07-06 | Docetaxel + Gemcitabine with GCSF | N | N | 330019500 | PAZOPANIB |
| 330004648 | 330002247 | 1.81 | 83.8 | Neo-adjuvant (N) | null | 2015-08-01 | Capecitabine (21days) + Carboplatin | 1 | N | 330019500 | FCIST |
| 330004649 | 330002248 | 1.78 | 59.7 | Adjuvant (A) | 2014-11-27 | 2014-12-06 | Temozolomide + RT | N | N | 330019510 | VEMURAFENIB |
| 330004650 | 330002249 | 1.8 | 76 | Palliative (P) | 2016-06-25 | 2016-12-25 | IMATINIB | 02 | Y | 330019525 | CARBOPLATIN + RT |
| 330004651 | 330002250 | null | 13.4 | Adjuvant (A) | 2013-11-19 | 2013-11-19 | OCTREOTIDE | N | null | 330019528 | FEC + DOCETAXEL |
| 330004652 | 330002250 | 1.85 | null | Disease modification (D) | 2016-06-25 | 2016-07-03 | Triple / Double Intrathecal Therapy | null | N | 330019528 | CISPLATIN + DOCETAXEL |
| 330004653 | 330002251 | 1.62 | null | Palliative (P) | null | 2014-10-05 | Cytarabine High Dose | null | null | 330019565 | TEMOZOLOMIDE |
| 330004654 | 330002251 | 1.56 | null | Palliative (P) | null | 2016-10-12 | CHLORAMBUCIL + RITUXIMAB | null | null | 330019565 | FLUOROURACIL + MITOMYCIN |
| 330004655 | 330009926 | 1.58 | 76 | null | 2017-03-19 | 2017-03-19 | Cyclophosphamide High Dose | null | null | 330019569 | CAPECITABINE |
| 330004656 | 330009927 | 1.81 | 103 | Curative (C) | 2013-04-09 | 2013-04-16 | Temozolomide 150mg/m2 | N | Y | 330019570 | DOXORUBICIN + IFOSFAMIDE |
| 330004657 | 330009927 | 1.68 | 55.5 | Curative (C) | 2014-04-22 | 2014-05-02 | ALL UKALL2011 Std Int Maint B | N | N | 330019570 | CETUXIMAB + CISPLATIN + FU |
| 330004658 | 330002252 | 1.84 | 81.1 | Curative (C) | 2016-10-23 | 2016-11-09 | IMATINIB | 02 | N | 330019580 | CARBOPLATIN + CETUXIMAB + FU |
| 330004660 | 330002253 | 1.69 | 74 | Palliative (P) | 2017-02-26 | 2017-04-13 | METHOTREXATE | 2 | Y | 330019583 | VISMODEGIB |
| 330004661 | 330002253 | null | null | Neo-adjuvant (N) | 2013-02-18 | 2013-02-18 | Carboplatin + Vinorelbine IV &PO D8 | N | N | 330019583 | CAPECITABINE + OXALIPLATIN |
| 330004662 | 330002253 | 1.8 | 66 | null | null | 2015-04-22 | Oxaliplatin + Modified de Gramont | 02 | null | 330019583 | BENDAMUSTINE |
| 330004667 | 330012237 | 1.56 | 56 | null | 2015-06-22 | 2015-06-22 | METHOTREXATE | N | N | 330019610 | AZACITIDINE |
| 330004668 | 330012237 | 1.76 | 65.4 | Palliative (P) | 2013-05-05 | 2013-05-05 | Doxorubicin + Ifosfamide | 2 | N | 330019610 | IMATINIB |
| 330004669 | 330012237 | 1.6 | 58.2 | null | null | 2014-01-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | null | null | 330019610 | DOCETAXEL + GEMCITABINE |
| 330004670 | 330002255 | 1.57 | 55.1 | null | 2017-02-03 | 2017-02-14 | GC Int Guide Excranial GermCell JEB | 02 | N | 330019614 | CAPECITABINE + CISPLATIN |
| 330004671 | 330002255 | null | 71 | Palliative (P) | 2017-04-01 | 2017-04-18 | VAC | N | N | 330019614 | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL |
| 330004672 | 330002256 | 1.72 | 97.5 | Palliative (P) | 2014-09-26 | 2014-10-13 | AML 19 TRIAL | null | N | 330019624 | CHOP R |
| 330004673 | 330002256 | 1.55 | 76.8 | Not known (9) | 2016-09-02 | 2016-09-02 | PCV | 2 | Y | 330019624 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL |
| 330004674 | 330002256 | null | 36 | Curative (C) | 2015-09-25 | 2015-09-30 | Melphalan IV High dose | N | N | 330019624 | CAV |
| 330004675 | 330002256 | null | 91.2 | Curative (C) | null | 2016-05-04 | CARBOPLATIN + RT | null | null | 330019624 | CETUXIMAB + CISPLATIN + FU |
| 330004676 | 330002257 | 1.74 | 66.8 | Palliative (P) | 2015-06-02 | 2015-06-03 | BEP 5 Day | N | N | 330019639 | CAPECITABINE + OXALIPLATIN |
| 330004677 | 330002257 | null | 13.2 | Curative (C) | 2017-06-05 | 2017-06-05 | Cytarabine High Dose | N | N | 330019639 | CAV |
| 330004678 | 330002257 | 1.62 | null | Disease modification (D) | null | 2017-10-09 | AML17 TRIAL | Y | N | 330019639 | TEMOZOLOMIDE |
| 330004679 | 330002258 | 0 | 55.7 | Curative (C) | 2013-09-12 | 2013-09-15 | Etoposide + Ifosfamide (3 days) | 2 | N | 330019665 | TCF |
| 330004680 | 330002259 | 1.85 | 42.3 | Palliative (P) | 2015-08-24 | 2015-08-24 | Cisplatin + Pemetrexed | N | N | 330019666 | FCIST |
| 330004681 | 330007249 | 1.62 | 122.9 | Curative (C) | 2013-10-11 | 2013-10-12 | TEMOZOLOMIDE | 02 | N | 330019667 | IMATINIB |